These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
238 related items for PubMed ID: 3478136
1. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells. Dell'Aquila ML, Nguyen HT, Herald CL, Pettit GR, Blumberg PM. Cancer Res; 1987 Nov 15; 47(22):6006-9. PubMed ID: 3478136 [Abstract] [Full Text] [Related]
2. Partial parallelism and partial blockade by bryostatin 1 of effects of phorbol ester tumor promoters on primary mouse epidermal cells. Sako T, Yuspa SH, Herald CL, Pettit GR, Blumberg PM. Cancer Res; 1987 Oct 15; 47(20):5445-50. PubMed ID: 2888531 [Abstract] [Full Text] [Related]
4. Differential effects of bryostatins and phorbol esters on arachidonic acid metabolite release and epidermal growth factor binding in C3H 10T1/2 cells. Dell'Aquila ML, Herald CL, Kamano Y, Pettit GR, Blumberg PM. Cancer Res; 1988 Jul 01; 48(13):3702-8. PubMed ID: 3132318 [Abstract] [Full Text] [Related]
5. Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations. Warren BS, Kamano Y, Pettit GR, Blumberg PM. Cancer Res; 1988 Nov 01; 48(21):5984-8. PubMed ID: 3167850 [Abstract] [Full Text] [Related]
6. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells. Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE. Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938 [Abstract] [Full Text] [Related]
7. A phorbol ester-binding inhibitory factor from human placenta. Partial purification, characterization and biological effects. Hamel E, Yamasaki H, Tayot JL. IARC Sci Publ; 1984 Jun 01; (56):157-64. PubMed ID: 6598799 [Abstract] [Full Text] [Related]
8. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol ester-induced differentiation of human promyelocytic leukemia cells HL-60. Kraft AS, Smith JB, Berkow RL. Proc Natl Acad Sci U S A; 1986 Mar 01; 83(5):1334-8. PubMed ID: 3456591 [Abstract] [Full Text] [Related]
9. Varied differentiation responses of human leukemias to bryostatin 1. Kraft AS, William F, Pettit GR, Lilly MB. Cancer Res; 1989 Mar 01; 49(5):1287-93. PubMed ID: 2917358 [Abstract] [Full Text] [Related]
10. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis. Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer L, Jarvis WD. Exp Cell Res; 1996 Oct 10; 228(1):65-75. PubMed ID: 8892972 [Abstract] [Full Text] [Related]
11. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1. Basu A, Lazo JS. Cancer Res; 1992 Jun 01; 52(11):3119-24. PubMed ID: 1591725 [Abstract] [Full Text] [Related]
12. Bryostatin induces changes in protein kinase C location and activity without altering c-myc gene expression in human promyelocytic leukemia cells (HL-60). Kraft AS, Baker VV, May WS. Oncogene; 1987 May 01; 1(2):111-8. PubMed ID: 3325877 [Abstract] [Full Text] [Related]
13. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression. Clark CS, Konyer JE, Meckling KA. Exp Cell Res; 2004 Mar 10; 294(1):301-11. PubMed ID: 14980523 [Abstract] [Full Text] [Related]
14. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1. Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR, Blumberg PM. Cancer Res; 1996 May 01; 56(9):2105-11. PubMed ID: 8616857 [Abstract] [Full Text] [Related]
15. Protein kinase calpha is an effector of hexamethylene bisacetamide-induced differentiation of Friend erythroleukemia cells. Mallia CM, Aguirre V, McGary E, Tang Y, Scandurro AB, Liu C, Noguchi CT, Beckman BS. Exp Cell Res; 1999 Feb 01; 246(2):348-54. PubMed ID: 9925750 [Abstract] [Full Text] [Related]
16. Hexamethylene bisacetamide-induced differentiation of Friend virus-transformed murine erythroleukemia cells is associated with parallel changes in casein kinase II and guanine nucleotide exchange factor activities. Aroor AR, Singh LP, Wahba AJ. Exp Hematol; 1995 Oct 01; 23(11):1204-11. PubMed ID: 7556531 [Abstract] [Full Text] [Related]
17. Effects of bryostatins and retinoic acid on phorbol ester- and diacylglycerol-induced squamous differentiation in human tracheobronchial epithelial cells. Jetten AM, George MA, Pettit GR, Rearick JI. Cancer Res; 1989 Jul 15; 49(14):3990-5. PubMed ID: 2567623 [Abstract] [Full Text] [Related]
18. Phorbol ester tumor promoters block the transition from the early to the heme-dependent late program of Friend cell differentiation. Mager D, Bernstein A. J Cell Physiol; 1980 Dec 15; 105(3):519-26. PubMed ID: 6936401 [Abstract] [Full Text] [Related]
19. Specific binding of phorbol esters to Friend erythroleukemia cells--general properties, down regulation and relationship to cell differentiation. Yamasaki H, Drevon C, Martel N. Carcinogenesis; 1982 Dec 15; 3(8):905-10. PubMed ID: 6957274 [Abstract] [Full Text] [Related]
20. Effect of hexamethylene bisacetamide on the commitment to differentiation of murine erythroleukemia cells. Fibach E, Reuben RC, Rifkind RA, Marks PA. Cancer Res; 1977 Feb 15; 37(2):440-4. PubMed ID: 264411 [Abstract] [Full Text] [Related] Page: [Next] [New Search]